A proposed merger between Aetna and CVS has come under fire from the Association of American Physicians and Surgeons (AAPS).
In a letter to Attorney General Jeff Sessions, AAPS President-elect Marilyn Singleton, MD, JD, said that the merger would be bad for patients.
“Mergers can decrease competition and such mergers are not in the interest of our patients,” Singleton wrote.
The merger would combine the third-largest health insurer and the largest national pharmacy chain, which has the dominant pharmacy benefits manager (PBM), CVS Caremark, the AAPS wrote in a statement.
“This merger is particularly troubling in light of the highly concentrated national market for PBM services and current lack of transparency in drug pricing and PBM contracts,” Singleton wrote.
Full Content: PR Newswire, Insurance Business America
Featured News
Alaska Airlines’ Hawaiian Acquisition Faces Antitrust Scrutiny
Dec 6, 2023 by
CPI
Ulmer & Greensfelder Merge to Form UB Greensfelder
Dec 6, 2023 by
CPI
Apple’s iMessage May Be Exempt from New EU Regulations
Dec 6, 2023 by
CPI
UK Watchdog Warns Firms on AI Privacy Compliance
Dec 6, 2023 by
CPI
FTC Mounts Second Challenge to Microsoft’s Activision Buy Despite Closed Deal
Dec 6, 2023 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Horizontal Competition: Mergers, Innovation & New Guidelines
Nov 30, 2023 by
CPI
Innovation in Merger Control
Nov 30, 2023 by
CPI
Making Sense of EU Merger Control: The Need for Limiting Principles
Nov 30, 2023 by
CPI
Sustainability Agreements in the EU: New Paths to Competition Law Compliance
Nov 30, 2023 by
CPI
Merger Control and Sustainability: A New Dawn or Nothing New Under the Sun?
Nov 30, 2023 by
CPI